{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:25:02Z","timestamp":1784287502716,"version":"3.55.0"},"reference-count":12,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T00:00:00Z","timestamp":1624665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Influenza Resp Viruses"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Well\u2010designed population\u2010based seroepidemiologic studies can be used to refine estimates of infection severity and transmission, and are therefore an important component of epidemic surveillance. However, the interpretation of the results of seroepidemiologic studies for SARS\u2010CoV\u20102 has been hampered to date principally by heterogeneity in the quality of the reporting of the results of the study and a lack of standardized methods and reporting. We provide here the ROSES\u2010S:\n                    <jats:styled-content>R<\/jats:styled-content>\n                    ep\n                    <jats:styled-content>o<\/jats:styled-content>\n                    rting of\n                    <jats:styled-content>S<\/jats:styled-content>\n                    ero\n                    <jats:styled-content>e<\/jats:styled-content>\n                    pidemiologic studies\u2014\n                    <jats:styled-content>S<\/jats:styled-content>\n                    ARS\u2010CoV\u20102. This is an updated checklist of 22 items that should be included in the reporting of all SARS\u2010CoV\u20102 seroepidemiologic studies, irrespective of study design.\n                  <\/jats:p>","DOI":"10.1111\/irv.12870","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T05:38:36Z","timestamp":1624685916000},"page":"561-568","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["ROSES\u2010S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS\u2010CoV\u20102"],"prefix":"10.1111","volume":"15","author":[{"name":"World Health Organization Seroepidemiology Technical Working Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,6,26]]},"reference":[{"key":"e_1_2_8_2_1","volume-title":"FIND evaluation of SARS\u2010COV\u20102 Antibody (AB) detection tests","author":"FIND","year":"2021"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10050319"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m2516"},{"issue":"6","key":"e_1_2_8_5_1","article-title":"Antibody tests for identification of current and past infection with SARS\u2010CoV\u20102","volume":"6","author":"Deeks JJ","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00879"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00301-9"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.10.020"},{"key":"e_1_2_8_9_1","article-title":"Global seroprevalence of SARS\u2010CoV\u20102 antibodies: a systematic review and meta\u2010analysis","author":"Bobrovitz N","year":"2020","journal-title":"MedRxiv"},{"key":"e_1_2_8_10_1","article-title":"Serological evidence of human infection with SARS\u2010CoV\u20102: a systematic review and meta\u2010analysis","author":"Chen X","year":"2020","journal-title":"Preprint. medRxiv"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2016.21.44.30388"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12411"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2014.07.013"}],"container-title":["Influenza and Other Respiratory Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/irv.12870","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/irv.12870","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/irv.12870","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T23:02:29Z","timestamp":1693263749000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/irv.12870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,26]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10.1111\/irv.12870"],"URL":"https:\/\/doi.org\/10.1111\/irv.12870","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1111\/IRV.12870\/v1\/decision1","asserted-by":"object"}]},"ISSN":["1750-2640","1750-2659"],"issn-type":[{"value":"1750-2640","type":"print"},{"value":"1750-2659","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,26]]},"assertion":[{"value":"2021-04-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}